Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Tumor suppressor functions of Dnmt3a and Dnmt3b in the prevention of malignant mouse lymphopoiesis

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Li Keqin Kathy, Luo Liu-Fei, Shen Yang, Xu Jie, Chen Zhu, Chen Sai-Juan . DNA methyltransferases in hematologic malignancies. Semin Hematol 2013; 50: 48–60.

    Article  CAS  PubMed  Google Scholar 

  2. Kim MS, Kim YR, Yoo NJ, Lee SH . Mutational analysis of DNMT3A gene in acute leukemias and common solid cancers. APMIS 2013; 121: 85–94.

    Article  CAS  PubMed  Google Scholar 

  3. Challen GA, Sun D, Jeong M, Luo M, Jelinek J, Berg JS et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet 2011; 44: 23–31.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Shah MY, Vasanthakumar A, Barnes NY, Figueroa ME, Kamp A, Hendrick C et al. DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis. Cancer Res 2010; 70: 5840–5850.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Hlady RA, Novakova S, Opavska J, Klinkebiel D, Peters SL, Bies J et al. Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis. J Clin Invest 2012; 122: 163–177.

    Article  CAS  PubMed  Google Scholar 

  6. Vasanthakumar A, Lepore JB, Zegarek MH, Kocherginsky M, Singh M, Davis EM et al. Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis. Blood 2013; 121: 2059–2063.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Nguyen S, Meletis K, Fu D, Jhaveri S, Jaenisch R . Ablation of de novo DNA methyltransferase Dnmt3a in the nervous system leads to neuromuscular defects and shortened lifespan. Dev Dyn 2007; 236: 1663–1676.

    Article  CAS  PubMed  Google Scholar 

  8. Peters SL, Hlady RA, Opavska J, Klinkebiel D, Novakova S, Smith LM et al. Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas. Mol Cell Biol 2013; 33: 4321–4333.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ji H, Ehrlich LI, Seita J, Murakami P, Doi A, Lindau P et al. Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature 2010; 467: 338–342.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Haferlach T, Kohlmann A, Wieczorek L, Basso G, Kronnie GT, Béné MC et al. Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. J Clin Oncol 2010; 28: 2529–2537.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Kulis M, Heath S, Bibikova M, Queirós AC, Navarro A, Clot G et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet 2012; 44: 1236–1242.

    Article  CAS  PubMed  Google Scholar 

  12. Palamarchuk A, Yan PS, Zanesi N, Wang L, Rodrigues B, Murphy M et al. Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL). Proc Natl Acad Sci USA 2012; 109: 2555–2560.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Walter MJ, Ding L, Shen D, Shao J, Grillot M, McLellan M et al. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 2011; 25: 1153–1158.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2012; 48: 506–510.

    Article  Google Scholar 

  15. Kaneda M, Okano M, Hata K, Sado T, Tsujimoto N, Li E et al. Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature 2004; 429: 900–903.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank the UNMC Flow Cytometry and Tissue Sciences Facilities. This work was supported by an Eppley Cancer Center pilot project grant (RO), the Nebraska Cancer and Smoking Disease Research Program NE DHHS LB506 2012-28 (RO), the National Center for Research Resources and the National Institutes of Health grant 5P20GM103489. RAH and SLP were supported by a UNMC assistanceship/fellowship.

Disclaimer

The funders had no role in study design, data collection and analysis, decision to publish, or in the preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peters, S., Hlady, R., Opavska, J. et al. Tumor suppressor functions of Dnmt3a and Dnmt3b in the prevention of malignant mouse lymphopoiesis. Leukemia 28, 1138–1142 (2014). https://doi.org/10.1038/leu.2013.364

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2013.364

This article is cited by

Search

Quick links